Here, we use the largest registry of combined genetics and clinical data for HCM to date, the Sarcomeric Human Cardiomyopathy Registry1 (SHaRe), to generate an adjudicated and comprehensive compendium of MYBPC3 variation, analyze regional variation within MYBPC3, and correlate clinical phenotypes. The gene discussed is MYBPC3; the disease is cardiomyopathy.